DALACIN V cr vag 2 % tb 40 g

7680521190140 CH-52119 G01AA10 09.03.0.
DALACIN V cr vag 2 % tb 40 g
DALACIN V cr vag 2 % tb 40 g
DALACIN V cr vag 2 % tb 40 g
1 / 3
google

Details

Product number
5211901
CPT
-
Packaging group
40
Unit
g
Composition
clindamycinum 20 mg ut clindamycini phosphas, sorbitani stearas, polysorbatum 60, propylenglycolum 50 mg, acidum stearicum, alcohol cetylicus et stearylicus 32.1 mg, cetylis palmitas, paraffinum liquidum, alcohol benzylicus 10 mg, aqua purificata, ad unguentum pro 1 g.

Articles (1)

Dalacin V 2%, Vaginalcreme
Vaginalcreme
40
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
13/06/2023
Patient information leaflet
Français
13/06/2023
Patient information leaflet
Italien
13/06/2023
Professional SmPC
Allemand
13/06/2023
Professional SmPC
Français
13/06/2023
Professional SmPC
Italien
13/06/2023

Detailed composition

Substance Quantity Type Category
(N/A)
20.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
50.0 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
32.1 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
10.0 MG Substance HBESI
(N/A)
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
52119
Drug name
Dalacin V 2%, Vaginalcreme
Galenic form
VAGC
ATC Code
G01AA10
Authorization status
Z
Dispensation category
B
First authorization
28/05/1993
Authorization expiration date
31/12/9999
IT number
09.03.0.
Domain
Human medicine
Field of application
Bakterielle Vaginosen

Packaging details

Description (FR)
DALACIN V cr vag 2 % tb 40 g
Description (DE)
DALACIN V Vag Cr 2 % Tb 40 g
Market launch
28/05/1993
Narcotic (BTM)
No

Other packaging sizes

DALACIN V cr vag 2 % tb 20 g
20 G
View